Cargando…

Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification

Objective: The aim of the study was to compare the prognoses between part-solid and pure-solid tumors for clinical stage IA non-small-cell lung cancer (NSCLC) patients in the eighth edition TNM classification. Methods: We searched the literature in PubMed and Web of Science for all eligible articles...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tian, Li, Ming, Lin, Miao, Zhao, Mengnan, Zhan, Cheng, Feng, Mingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497478/
https://www.ncbi.nlm.nih.gov/pubmed/31114343
http://dx.doi.org/10.2147/CMAR.S196613
_version_ 1783415476839251968
author Jiang, Tian
Li, Ming
Lin, Miao
Zhao, Mengnan
Zhan, Cheng
Feng, Mingxiang
author_facet Jiang, Tian
Li, Ming
Lin, Miao
Zhao, Mengnan
Zhan, Cheng
Feng, Mingxiang
author_sort Jiang, Tian
collection PubMed
description Objective: The aim of the study was to compare the prognoses between part-solid and pure-solid tumors for clinical stage IA non-small-cell lung cancer (NSCLC) patients in the eighth edition TNM classification. Methods: We searched the literature in PubMed and Web of Science for all eligible articles published before November 31, 2018. The pooled data included overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS). The hazard ratio (HR) of OS (pure-solid/part-solid) was used as the measure of differential effects. Pure-solid or part-solid tumors in all studies included were matched according to the solid component size or according to the eighth edition TNM classification. Results: Seven studies including 2,037 patients with c-stage IA NSCLC were pooled in the meta-analysis. Patients with pure-solid tumors had significantly poorer OS (HR 1.69, 95% CI 1.21‒2.35, P=0.002), DFS (HR 1.27, 95% CI 1.07‒1.51, P=0.006) and RFS (HR 1.74, 95% CI 1.08‒2.80, P=0.020). In subgroup analyses, when the meta-analysis was limited to T1a-1b (≤2 cm) lung cancer, the prognosis for pure-solid tumors was inferior to that for part-solid tumors regarding both OS and RFS. In adenocarcinoma subgroup, there was no difference between the two groups in terms of OS and RFS, but we detected a meaningful difference in DFS. Conclusion: Part-solid tumors may have a better prognosis than pure-solid tumors in clinical stage IA patients according to the eighth edition TNM classification, and similar results were found for the T1a-1b (≤2 cm) subgroup. There were no substantial differences in OS and RFS between two groups in lung adenocarcinoma. However, we detected a meaningful difference in DFS, which might also suggest a superior prognosis for part-solid tumors. We propose that the part-solid and pure-solid tumors in the same T component category be considered separately.
format Online
Article
Text
id pubmed-6497478
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-64974782019-05-21 Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification Jiang, Tian Li, Ming Lin, Miao Zhao, Mengnan Zhan, Cheng Feng, Mingxiang Cancer Manag Res Original Research Objective: The aim of the study was to compare the prognoses between part-solid and pure-solid tumors for clinical stage IA non-small-cell lung cancer (NSCLC) patients in the eighth edition TNM classification. Methods: We searched the literature in PubMed and Web of Science for all eligible articles published before November 31, 2018. The pooled data included overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS). The hazard ratio (HR) of OS (pure-solid/part-solid) was used as the measure of differential effects. Pure-solid or part-solid tumors in all studies included were matched according to the solid component size or according to the eighth edition TNM classification. Results: Seven studies including 2,037 patients with c-stage IA NSCLC were pooled in the meta-analysis. Patients with pure-solid tumors had significantly poorer OS (HR 1.69, 95% CI 1.21‒2.35, P=0.002), DFS (HR 1.27, 95% CI 1.07‒1.51, P=0.006) and RFS (HR 1.74, 95% CI 1.08‒2.80, P=0.020). In subgroup analyses, when the meta-analysis was limited to T1a-1b (≤2 cm) lung cancer, the prognosis for pure-solid tumors was inferior to that for part-solid tumors regarding both OS and RFS. In adenocarcinoma subgroup, there was no difference between the two groups in terms of OS and RFS, but we detected a meaningful difference in DFS. Conclusion: Part-solid tumors may have a better prognosis than pure-solid tumors in clinical stage IA patients according to the eighth edition TNM classification, and similar results were found for the T1a-1b (≤2 cm) subgroup. There were no substantial differences in OS and RFS between two groups in lung adenocarcinoma. However, we detected a meaningful difference in DFS, which might also suggest a superior prognosis for part-solid tumors. We propose that the part-solid and pure-solid tumors in the same T component category be considered separately. Dove 2019-04-10 /pmc/articles/PMC6497478/ /pubmed/31114343 http://dx.doi.org/10.2147/CMAR.S196613 Text en © 2019 Jiang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jiang, Tian
Li, Ming
Lin, Miao
Zhao, Mengnan
Zhan, Cheng
Feng, Mingxiang
Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification
title Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification
title_full Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification
title_fullStr Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification
title_full_unstemmed Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification
title_short Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification
title_sort meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage ia non-small-cell lung cancer in the eighth edition tnm classification
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497478/
https://www.ncbi.nlm.nih.gov/pubmed/31114343
http://dx.doi.org/10.2147/CMAR.S196613
work_keys_str_mv AT jiangtian metaanalysisofcomparingpartsolidandpuresolidtumorsinpatientswithclinicalstageianonsmallcelllungcancerintheeightheditiontnmclassification
AT liming metaanalysisofcomparingpartsolidandpuresolidtumorsinpatientswithclinicalstageianonsmallcelllungcancerintheeightheditiontnmclassification
AT linmiao metaanalysisofcomparingpartsolidandpuresolidtumorsinpatientswithclinicalstageianonsmallcelllungcancerintheeightheditiontnmclassification
AT zhaomengnan metaanalysisofcomparingpartsolidandpuresolidtumorsinpatientswithclinicalstageianonsmallcelllungcancerintheeightheditiontnmclassification
AT zhancheng metaanalysisofcomparingpartsolidandpuresolidtumorsinpatientswithclinicalstageianonsmallcelllungcancerintheeightheditiontnmclassification
AT fengmingxiang metaanalysisofcomparingpartsolidandpuresolidtumorsinpatientswithclinicalstageianonsmallcelllungcancerintheeightheditiontnmclassification